Pharmaceuticals, Biotechnology and Life Sciences
— Data from the RLYB212 Phase 1b Proof-of-Concept Study to be Featured as an Oral Presentation at ISTH — —…
Proxy Cards Must be Received by 10:00 AM EDT on Tuesday, June 13th for Votes to Count Encourages Shareholders to…
DUBLIN–(BUSINESS WIRE)–The “US Pharma Packaging Market – Focused Insights 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The US pharmaceutical…
– The COMMODORE 2 study demonstrated that subcutaneous crovalimab every four weeks was non-inferior to intravenous eculizumab every two weeks,…
DUBLIN–(BUSINESS WIRE)–The “Chinese Biopharma, Clinical Development, CRO Utilization and Outlook 2023” report has been added to ResearchAndMarkets.com’s offering. This report…
CONSHOHOCKEN, Pa. & SAN FRANCISCO & FORT WORTH, Texas–(BUSINESS WIRE)–TPG (NASDAQ: TPG), a global alternative asset management firm, and AmerisourceBergen…
DUBLIN–(BUSINESS WIRE)–The “APAC Vaccine Packaging Market – Focused Insights 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The APAC vaccine…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that Seres Therapeutics management, will participate…
DUBLIN–(BUSINESS WIRE)–The “The Global Exosome Market – Market Size, Forecast, Trials, and Trends, 2023” report has been added to ResearchAndMarkets.com’s…
Results from phase 1/2 EPCORE™ NHL-2 trial investigating epcoritamab in combination with rituximab-lenalidomide (R2) showed a 98 percent overall response…